Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ)
CNY 8.67
(0.58%)
CNY 8.67
(0.58%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 204.89 Million CNY | 26.17% |
| 2022 | 162.4 Million CNY | 0.59% |
| 2021 | 161.44 Million CNY | 0.94% |
| 2020 | 159.94 Million CNY | 887.57% |
| 2019 | 16.19 Million CNY | 335.23% |
| 2018 | 3.72 Million CNY | -4.76% |
| 2017 | 3.9 Million CNY | -59.55% |
| 2016 | 9.66 Million CNY | -82.12% |
| 2015 | 54.01 Million CNY | -16.39% |
| 2014 | 64.6 Million CNY | 123.55% |
| 2013 | 28.9 Million CNY | 380.97% |
| 2012 | 6 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 258.83 Million CNY | 47.76% |
| 2024 Q2 | 184.28 Million CNY | -10.23% |
| 2024 Q1 | 203.02 Million CNY | -0.21% |
| 2023 Q3 | 207.73 Million CNY | 0.05% |
| 2023 Q4 | 204.89 Million CNY | -1.36% |
| 2023 FY | 204.89 Million CNY | 26.17% |
| 2023 Q1 | 165.35 Million CNY | 1.82% |
| 2023 Q2 | 207.63 Million CNY | 25.57% |
| 2022 Q3 | 166.36 Million CNY | 0.68% |
| 2022 Q2 | 165.24 Million CNY | 14.56% |
| 2022 Q1 | 144.25 Million CNY | -10.65% |
| 2022 FY | 162.4 Million CNY | 0.59% |
| 2022 Q4 | 162.4 Million CNY | -2.38% |
| 2021 FY | 161.44 Million CNY | 0.94% |
| 2021 Q4 | 161.44 Million CNY | -5.15% |
| 2021 Q2 | 169.22 Million CNY | -1.73% |
| 2021 Q1 | 172.2 Million CNY | 7.66% |
| 2021 Q3 | 170.2 Million CNY | 0.58% |
| 2020 Q4 | 159.94 Million CNY | -0.49% |
| 2020 FY | 159.94 Million CNY | 887.57% |
| 2020 Q1 | 158.25 Million CNY | 877.12% |
| 2020 Q2 | 159.41 Million CNY | 0.73% |
| 2020 Q3 | 160.73 Million CNY | 0.83% |
| 2019 Q2 | 3.65 Million CNY | -1.12% |
| 2019 FY | 16.19 Million CNY | 335.23% |
| 2019 Q4 | 16.19 Million CNY | -14.76% |
| 2019 Q3 | 19 Million CNY | 420.49% |
| 2019 Q1 | 3.69 Million CNY | -0.8% |
| 2018 Q1 | 3.82 Million CNY | -2.01% |
| 2018 Q2 | 3.77 Million CNY | -1.31% |
| 2018 FY | 3.72 Million CNY | -4.76% |
| 2018 Q3 | 3.73 Million CNY | -1.06% |
| 2018 Q4 | 3.72 Million CNY | -0.45% |
| 2017 Q4 | 3.9 Million CNY | -0.54% |
| 2017 FY | 3.9 Million CNY | -59.55% |
| 2017 Q1 | 9.66 Million CNY | 0.0% |
| 2017 Q2 | 3.95 Million CNY | -59.03% |
| 2017 Q3 | 3.92 Million CNY | -0.74% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 Q4 | 9.66 Million CNY | 0.0% |
| 2016 FY | 9.66 Million CNY | -82.12% |
| 2016 Q2 | 48.72 Million CNY | 0.0% |
| 2015 Q3 | 54.01 Million CNY | -8.93% |
| 2015 Q4 | 54.01 Million CNY | 0.0% |
| 2015 Q2 | 59.31 Million CNY | 0.0% |
| 2015 Q1 | 59.31 Million CNY | -8.2% |
| 2015 FY | 54.01 Million CNY | -16.39% |
| 2014 FY | 64.6 Million CNY | 123.55% |
| 2014 Q4 | 64.6 Million CNY | 0.0% |
| 2014 Q3 | 64.6 Million CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2013 FY | 28.9 Million CNY | 380.97% |
| 2012 FY | 6 Million CNY | 0.0% |